Career Center



Industry Insights - Standing on the Bridge Between Medical Science and Finance: Perspectives from the Founder of Panorama Capital
Date: November 11, 2008
Time: 12:00-1:30 PM
Location: Clark Auditorium
Sponsor: SoMCC
Event details: Overview:

There are tremendous opportunities for both clinicians and researchers to make significant contributions and build satisfying careers at the points where banking, finance, and medical science intersect.  Bioscience companies, venture firms, public investors, and investment banks rely heavily on individuals with strong backgrounds in science and medicine to evaluate and modify research priorities, clinical/regulatory risk, commercial differentiation and potential, and many other business decisions.  This program offers a unique opportunity to hear from an accomplished Stanford scientist, physician, and globally recognized expert in financing young biotech companies on the following:

- dynamics between biomedical and business professionals
- balancing interest and dedication to medicine/science with investment interests
- how and why MD and PhD backgrounds are valued in this sector
- steps for entry - what one can do to learn more and become more involved in this field
- the importance of operating experience as part of the training process
- typical roles that researchers and clinicians perform across levels
- required business skills and savvy, and how to develop them

About our Speaker:  
Srini Akkaraju is co-founder and Managing Director of Panorama Capital LCC and focuses primarily on life sciences investments.  He joined JPMorgan Partners in 2001 and in 2006 spun out with the JPMP venture group to form Panorama.  From 1998 to 2001, Dr. Akkaraju was in Business and Corporate Development at Genentech, Inc., most recently as Senior Manager responsible for worldwide partnering activities, in-licensing of therapeutics, and out-licensing of development projects.  In addition to his business development role, Dr. Akkaraju also served as a Project Team Leader for one of Genentech’s clinical development products. During this time, he also was a founding member of BioStreet, an online marketplace for biotech opportunities.  Srini is on the board of directors for the following companies: Seattle Genetics (SGEN), Amarin Corp (AMRN), Itero Biopharmaceuticals (private), Phenomix Corp (private), Presidio Pharmaceuticals, and Pharmos Corp (PARS).

Dr. Akkaraju holds BA degrees in Biochemistry and Computer Science from Rice University, and an MD and PhD in Immunology from Stanford School of Medicine.

Fee: Free and open to Stanford ID holders.
Additional information and/or registration: RSVP required. Register online

Footer Links: